PLK1 and osteosarcoma: It also has antitumor potential, being capable of inducing apoptosis in tumor cells by inhibiting the PLK1 (polo-like kinase 1) enzyme, which is involved in the development of several types of cancer, such as osteosarcoma and myeloma19,20.